Remarkably, in kidney disease mouse models in which EMPA did not induce an initial dip of the GFR, no nephroprotection could be observed by EMPA treatment highlighting the importance of GFR control for EMPA-mediated nephroprotection (Tauber et al., 2021). The gene discussed is RAPGEF5; the disease is kidney disorder.